Two new options that provide significant blood pressure (BP) reduction — one a novel drug, the other a low-dose triple therapy — and the effectiveness of renal denervation (RDN) for treatment ...

Sign Up for Wine Spectator’s Free Email Newsletters and stay up-to-date with all things wine.